Studies with cancer cell lines treated with chemotherapeutic agents demonstrated that p21 forms a positive regulatory loop with ATM and that this interaction is essential for the maintenance of the growth-arrested response, a hallmark of SIPS [32,61]; pharmacological targeting of either p21 or ATM triggers apoptosis of growth-arrested cancer cells [61]. Here, CDKN1A is linked to cancer.